Effects of short-term prednisolone intake during submaximal exercise

Medicine and Science in Sports and Exercise

Volumn 39, Issue 9, 2007, Pages 1672-1678

  Arlettaz, Alexandre ^a,d   Portier, Hugues ^a   Lecoq, Anne Marie ^a,b   Rieth, Nathalie ^a   De Ceaurriz, Jacques ^c   Collomp, Katia ^a,c  

^a LAPSEP   (France)

^b CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^c LNDD   (France)

^d UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

ACTH; GH blood glucose; Glucocorticoid; Time to exhaustion

Indexed keywords

CORTICOTROPIN; GLUCOSE; GROWTH HORMONE; INSULIN; LACTIC ACID; LACTOSE; OXYGEN; PLACEBO; PRASTERONE; PREDNISOLONE; PROLACTIN;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; ATHLETE; BLOOD SAMPLING; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; EXERCISE; EXHAUSTION; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; MALE; METABOLISM; NORMAL HUMAN; OXYGEN CONSUMPTION; PROLACTIN BLOOD LEVEL; SHORT COURSE THERAPY; TASK PERFORMANCE;

ADMINISTRATION, ORAL; ADULT; ANAEROBIC THRESHOLD; ANTI-INFLAMMATORY AGENTS; ATHLETIC PERFORMANCE; BICYCLING; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; GLUCOCORTICOIDS; HUMANS; MALE; PHYSICAL ENDURANCE; PREDNISOLONE; RUNNING;

EID: 34548458465     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/mss.0b013e3180dc992c     Document Type: Article

References (25)

1. ALMEKINDERS, L. C. Nonosteroidal anti-inflammatory drugs and corticosteroids. In: Performance-Enhancing Substances in Sport and Exercise, M. Bahrke and C. Yesalis (Eds.). Champaign, IL: Human Kinetics, pp. 125-136, 2002.
2. ARLETTAZ, A., K. COLLOMP, H. PORTIER, A.-M. LECOQ, A. PELLÉ, and J. DE CEAURRIZ. Effect of acute prednisolone intake during intense submaximal exercise. Int. J. Sports Med. 27:673-679, 2006.
3. ARLETTAZ, A., H. PORTIER, A.-M. LECOQ, Z. LABSY, J. DE CEAURRIZ, and K. COLLOMP. Effect of acute prednisolone intake on substrate utilization during submaximal exercise. Int. J. Sports Med. (in press).
4. BAILEY, S. P., J. M. DAVIS, and E. N. AHLBORN. Serotonergic agonists and antagonists affect endurance performance in the rat. Int. J. Sports Med. 14:330-333, 1993.
5. CARO, J. F., and J. M. AMATRUDA. Glucocorticoid-induced insulin resistance-the importance of postbinding events in the regulation of insulin binding, action and degradation in freshly isolated and primary cultures of rat hepatocytes. J. Clin. Invest. 69:866-875, 1982.
6. COX, J. S. Current concepts in the role of steroids in the treatment of sprains and strains. Med. Sci. Sports Exerc. 16:216-218, 1984.
7. DAVIS, J. M. Central and peripheral factors in fatigue. J. Sports Med. 13:S49-53, 1995.
8. DEUSTER, P. A., G. P. CHROUSOS, A. LUGER, et al. Hormonal and metabolic responses of untrained, moderately trained and highly trained men to three exercise intensities. Metabolism 38:141-148, 1989.
9. DEUSTER, P. A., J. S. PETRIDES, A. SINGH, E. B. LUCCI, G. P. CHROUSOS, and P. W. GOLD. High intensity exercise promotes escape of adrenocorticotropin and cortisol from suppression by dexamethasone: sexually dimporphic responses. J. Clin. Endocrinol. Metab. 83:3332-3338, 1998.
10. DWYER, D., and J. FLYNN. Short term aerobic exercise training in young males does not alter sensitivity to a central serotonin agonist. Exp. Physiol. 87:83-89, 2002.
11. FERNER, R. E. Drug-induced diabetes. Baillieres Clin. Endocrinol. Metab. 6:849-866, 1992.
12. GERTZ, B. J., D. G. SCIBERRAS, L. YOGENDRAN, et al. L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J. Clin. Endocrinol. Metab. 79:745-749, 1994.
13. GIUSTINA, A., A. GIRELLI, D. ALBERTI, et al. Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin. Endocrinol. 35:491-498, 1991.
14. HEDNER, P., G. KULLBERG, and I. BOSTEDT. Recovery of the hypothalamus-pituitary-adrenal axis after short term high dose corticosteroid treatment in neurosurgical practice. Acta Neurochir. 73:157-163, 1984.
15. HOCHBERG, Z. Mechanisms of steroid impairment of growth. Horm. Res. 58(Suppl 1):33-38, 2002.
16. LOW, D., T. CABLE, and A. PURVIS. Exercise thermoregulation and hyperprolactinaemia. Ergonomics 48:1547-1557, 2005.
17. MARQUET, P., G. LAC, A. P. CHASSAIN, G. HABRIOUX, and F. X. GALEN. Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones. J. Appl. Physiol. 87:175-182, 1999.
18. MCMAHON, M., J. GERICH, and R. RIZZA. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab. Rev. 4:17-30, 1988.
19. MEEUSEN, R., and M. F. PIACENTINI. Exercise, fatigue, neurotransmission and the influence of the neuroendocrine axis. Adv. Exp. Med. Biol. 527:521-525, 2003.
20. PERLEY, M., and D. M. KIPNIS. Effects of glucocorticoids on plasma insulin. N. Engl. J. Med. 274:1237-1241, 1966.
21. PETRIDES, J. S., P. W. GOLD, G. P. MUELLER, et al. Marked differences in functionning of the hypothalamic-pituitary-adrenal axis between groups of men. J. Appl. Physiol. 82:1979-1988, 1997.
22. RUPPRECHT, M., R. RUPPRECHT, H. U. KOCH, D. HAACK, O. A. MULLER, and O. P. HORNSTEIN. Multihormonal response to dexamethasone. A study in atopic dermatitis and normal controls. Acta Derm. Venereol. 71:214-218, 1991.
23. SOETENS, E., K. DE MEIRLEIR, and J. E. HUETING. No influence of ACTH on maximal performance. Psychopharmacolgoy (Berl.) 118:260-266, 1995.
24. SWINBURN, C. R., J. M. WAKEFIELD, S. P. NEWMAN, and P. W. JONES. Evidence of prednisolone induces mood change ('steroid euphoria') in patients with chronic obstructive airways disease. Br. J. Clin. Pharmacol. 26:709-713, 1988.
25. VONDRACEK, S. F., and B. A. HEMSTREET. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease? Pharmacotherapy 26:522-532, 2006.